← Eichor
Study identifier: NCT06777758 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Comparison of Remimazolam and Propofol in Endoscopic Examinations and Treatments

Condition: Postoperative Complications · Respiratory Depression · Postoperative Nausea  ·  Sponsor: Kaohsiung Veterans General Hospital.

PhasePhase 4
Planned participants90
Who can joinAll sexes, 20 Years to 80 Years
Healthy volunteersNo

About this study

This study aims to evaluate the efficacy and safety of Remimazolam, either used alone or in combination with Propofol, for moderate sedation anesthesia during endoscopic therapies or examinations. Additionally, it seeks to explore whether their combination can further enhance the quality of patient anesthesia and recovery outcomes.

This description comes directly from the study's public registry record.

Talk to the study team

Yuan-Yi Chia, M.D  ·  886-7-342-2121  ·  yychia@vghks.gov.tw

Chen-Hsiu Chen, Ph.D  ·  886-7-342-2121  ·  chschen@vghks.gov.tw

Always discuss trial participation with your own doctor first.

Locations (1)

Kaohsiung Veterans General HospitalKaohsiung City, TaiwanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06777758